SIG
54
2
CCL
68
8
ECL
54
2
UA
29
3
SO
46
2
PLD
48
2
INTU
65
3
KR
29
-8
XYL
47
6
AVY
53
6
SCHW
58
2
CF
48
6
ICE
67
4
M
59
6
HD
34
6
BBY
48
2
BWA
61
2
MOS
40
11
CNX
59
-4
CAG
43
2
SIG
54
2
CCL
68
8
ECL
54
2
UA
29
3
SO
46
2
PLD
48
2
INTU
65
3
KR
29
-8
XYL
47
6
AVY
53
6
SCHW
58
2
CF
48
6
ICE
67
4
M
59
6
HD
34
6
BBY
48
2
BWA
61
2
MOS
40
11
CNX
59
-4
CAG
43
2
Financhill
Back

Manhattan Associates, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
44

MANH
Manhattan Associates, Inc.

Last Price:
$173.15
Seasonality Move:
6.39%
Sell
33

NKTR
Nektar Therapeutics

Last Price:
$51.10
Seasonality Move:
11.58%
Sell
44
Manhattan Associates, Inc. (MANH) is a Sell

Is Manhattan Associates, Inc. a Buy, Sell or Hold?

  • The current Manhattan Associates, Inc. [MANH] share price is $173.19. The Score for MANH is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • MANH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MANH Stock Price Chart

What is Manhattan Associates, Inc.'s stock price today?

  • The Manhattan Associates, Inc. share price today is $173.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MANH is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $51.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

MANH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.2 Sell
Relative Strength Index (14 RSI): 39.61 Sell
Chaikin Money Flow: -405221 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (172.33 - 178.03) Sell
Bollinger Bands (100): (182.09 - 217.07) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 39.75 Sell
Chaikin Money Flow: -893008 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.73 - 61.07) Sell
Bollinger Bands (100): (32.3 - 62.42) Buy

MANH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 176.63 Sell
20-day SMA: 174.98 Sell
50-day SMA: 184.52 Sell
200-day SMA: 190.9 Sell
8-day EMA: 175.52 Sell
20-day EMA: 176.69 Sell
50-day EMA: 183.86 Sell
200-day EMA: 200.1 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.44 Sell
20-day SMA: 58.08 Sell
50-day SMA: 58.52 Sell
200-day SMA: 30.43 Buy
8-day EMA: 56.58 Sell
20-day EMA: 57.71 Sell
50-day EMA: 55.82 Sell
200-day EMA: 37.69 Buy

Manhattan Associates, Inc. Earnings Growth & MANH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.41 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Manhattan Associates, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):